Abiopharma

New Form 8-K - Voyager Therapeutics, Inc. Filed: 2025-09-02 AccNo: 0001104659-25-085977 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits